AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32885352 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (HDD)
Number of subjects: 211
Study 32885352 — intervention group
Group type: COMPARATOR
Intervention: Standard prednisone (PDN)
Number of subjects: 211
Study 35364022 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV booster after 1 year
Number of subjects: 1050
Study 35364022 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV booster after 2 years
Number of subjects: 1050
Study 35364022 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV booster after 1 year (two-dose primary schedule)
Number of subjects: 1050
Study 35364022 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV booster after 2 years (two-dose primary schedule)
Number of subjects: 1050
Study 35364022 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV booster (1 year or 2 years)
Number of subjects: 1050
Study 34526950 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (twice daily for 5 days, blood pressure cuff inflated to 20 mmHg above systolic blood pressure, up to 180 mmHg)
Number of subjects: 40
Study 34526950 — intervention group
Group type: COMPARATOR
Intervention: Sham group (blood pressure cuff inflated to 30 mmHg)
Number of subjects: 40
Study 34526950 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (NIHSS)
Number of subjects: 40
Study 34526950 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PHQ-9)
Number of subjects: 40
Study 34526950 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Number of subjects: 40
Study 32347270 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) 1 gram (830 mg of GTP) with quercetin (Q) 800 mg
Number of subjects: 31
Study 32347270 — intervention group
Group type: COMPARATOR
Intervention: Placebo (GT + PL)
Number of subjects: 31
Study 32347270 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) with quercetin (Q)
Number of subjects: 31
Study 33544719 — intervention group
Group type: EXPERIMENTAL
Intervention: log-GGT
Number of subjects: 709
Study 32492734 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga with blood flow restriction bands
Number of subjects: 20
Study 32492734 — intervention group
Group type: COMPARATOR
Intervention: Yoga without blood flow restriction bands
Number of subjects: 20
Study 33673741 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-being (WB) spectrum psychological traits (PT)
Number of subjects: 0
Study 33673741 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse well-being traits like neuroticism
Number of subjects: 0
Study 34412860 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand group
Number of subjects: 96
Study 34412860 — intervention group
Group type: COMPARATOR
Intervention: Sit group
Number of subjects: 96
Study 32196390 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Communication Education (ACE) programme
Number of subjects: 66
Study 32196390 — intervention group
Group type: COMPARATOR
Intervention: Cognitive stimulation programme
Number of subjects: 66
Study 616474479 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide-coated bioactive stents (BAS)
Number of subjects: 827
Study 616474479 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 827
Study 33770276 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic pancreaticoduodenectomy (RPD)
Number of subjects: 130
Study 34625083 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous leisure-time physical activity (LPA)
Number of subjects: 1464
Study 34625083 — intervention group
Group type: COMPARATOR
Intervention: Moderate leisure-time physical activity (LPA)
Number of subjects: 1464
Study 32359392 — intervention group
Group type: EXPERIMENTAL
Intervention: Germination experiment at 0, -4 bar and -8 bar levels
Number of subjects: 3
Study 32359392 — intervention group
Group type: EXPERIMENTAL
Intervention: IS10 and IS15 primers
Number of subjects: 3
Study 32359392 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromosome analysis
Number of subjects: 3
Study 36371213 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory rhythmical cueing (ARC) gait and balance training programme
Number of subjects: 59
Study 36371213 — intervention group
Group type: COMPARATOR
Intervention: Training programme without ARC (control)
Number of subjects: 59
Study 36371213 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study 33486572 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of 10 g viscous fiber, 60 g white chia seeds, 1.5 g American ginseng, and 0.75 g Korean ginseng extracts
Number of subjects: 104
Study 33486572 — intervention group
Group type: COMPARATOR
Intervention: Energy and fiber-matched control (53 g oat bran, 25 g inulin, 25 g maltodextrin, and 2.25 g wheat bran)
Number of subjects: 104
Study 33025690 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/kg IV acetaminophen
Number of subjects: 71
Study 33025690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 32441473 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide 2.4 mg once weekly subcutaneously
Number of subjects: 5000
Study 32441473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5000
Study 34453286 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher analytic thinking levels (measured by the Cognitive Reflection Test)
Number of subjects: 742
Study 34453286 — intervention group
Group type: COMPARATOR
Intervention: Claims about COVID-19 (half debunked misinformation, half endorsed by public health agencies)
Number of subjects: 742
Study 33332726 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.1 mg/kg and 1 mg/kg) for 10 days
Number of subjects: 84
Study 33332726 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (30 mg/kg) as positive control
Number of subjects: 84
Study 33332726 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (10 ml/kg) as negative control
Number of subjects: 84
Study 32075823 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based doula support (CBD)
Number of subjects: 200
Study 32075823 — intervention group
Group type: COMPARATOR
Intervention: Standard labour support
Number of subjects: 200
Study 35094120 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (breathing exercises + manual therapy)
Number of subjects: 60
Study 35094120 — intervention group
Group type: COMPARATOR
Intervention: Breathing exercises
Number of subjects: 60
Study 35094120 — intervention group
Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 60
Study 35094120 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 34256550 — intervention group
Group type: EXPERIMENTAL
Intervention: 34 kcal of a fructose solution daily for 5 days
Number of subjects: 6
Study 34256550 — intervention group
Group type: COMPARATOR
Intervention: Water for the first 5 days followed by 34 kcal fructose solution
Number of subjects: 6
Study 32057907 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release formulations containing a model drug of BCS class III
Number of subjects: 4
Study 32057907 — intervention group
Group type: EXPERIMENTAL
Intervention: AGS with programmable 'pyloric' valve
Number of subjects: 4
Study 32057907 — intervention group
Group type: COMPARATOR
Intervention: Conventional dissolution method
Number of subjects: 4
Study 34618687 — intervention group
Group type: EXPERIMENTAL
Intervention: PR3+ B cells in participants with PR3-AAV
Number of subjects: 154
Study 32965655 — intervention group
Group type: EXPERIMENTAL
Intervention: Cal/BD foam applied twice weekly for up to 52 weeks
Number of subjects: 0
Study 32965655 — intervention group
Group type: COMPARATOR
Intervention: Foam vehicle applied twice weekly for up to 52 weeks (control)
Number of subjects: 0
Study 32965655 — intervention group
Group type: EXPERIMENTAL
Intervention: Cal/BD foam (rescue therapy) applied once daily for 4 weeks on active areas
Number of subjects: 0
Study 32965655 — intervention group
Group type: EXPERIMENTAL
Intervention: Cal/BD foam applied twice weekly
Number of subjects: 0
Study 32965655 — intervention group
Group type: COMPARATOR
Intervention: Foam vehicle applied twice weekly (control)
Number of subjects: 0
Study 36210015 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft drink prime (participants saw images with cola)
Number of subjects: 964
Study 36210015 — intervention group
Group type: EXPERIMENTAL
Intervention: Water prime (participants saw images with water)
Number of subjects: 964
Study 36210015 — intervention group
Group type: COMPARATOR
Intervention: Control (participants saw images with no drink)
Number of subjects: 964
Study 33423549 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical therapy
Number of subjects: 86
Study 33423549 — intervention group
Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 86
Study 35135323 — intervention group
Group type: EXPERIMENTAL
Intervention: Second cohort (endovascular treatment)
Number of subjects: 1692
Study 34487920 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 10 J/cm2 plus conventional treatment
Number of subjects: 80
Study 34487920 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 8 J/cm2 plus conventional treatment
Number of subjects: 80
Study 34487920 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 4 J/cm2 plus conventional treatment
Number of subjects: 80
Study 34487920 — intervention group
Group type: COMPARATOR
Intervention: Placebo LLLT plus conventional treatment
Number of subjects: 80
Study 33844276 — intervention group
Group type: EXPERIMENTAL
Intervention: Providers without advanced degrees
Number of subjects: 182
Study 33844276 — intervention group
Group type: COMPARATOR
Intervention: Providers with advanced degrees
Number of subjects: 182
Study 36460015 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 1082
Study 36460015 — intervention group
Group type: COMPARATOR
Intervention: Lying position
Number of subjects: 1082
Study 36460015 — intervention group
Group type: EXPERIMENTAL
Intervention: Early stylet removal
Number of subjects: 1082
Study 36460015 — intervention group
Group type: COMPARATOR
Intervention: Late stylet removal
Number of subjects: 1082
Study 32112254 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D imaging system
Number of subjects: 26
Study 32112254 — intervention group
Group type: COMPARATOR
Intervention: 2D imaging system
Number of subjects: 26
Study 32112254 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D/3D transition
Number of subjects: 26
Study 32112254 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D/2D transition
Number of subjects: 26
Study 36136791 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced incentive (EI) condition
Number of subjects: 38
Study 36136791 — intervention group
Group type: COMPARATOR
Intervention: Standard incentive (SI) condition
Number of subjects: 38
Study 34559101 — intervention group
Group type: EXPERIMENTAL
Intervention: Yijinjing exercise for 4 months in addition to conventional treatment
Number of subjects: 0
Study 34559101 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with maintained current lifestyle
Number of subjects: 0
Study 32005308 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aminoglycoside group (≥75 mg/kg/week)
Number of subjects: 0
Study 32005308 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-existing hearing loss
Number of subjects: 0
Study 32005308 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (per 10 years)
Number of subjects: 0
Study 35301596 — intervention group
Group type: EXPERIMENTAL
Intervention: Office bleaching
Number of subjects: 260
Study 35301596 — intervention group
Group type: EXPERIMENTAL
Intervention: Home bleaching
Number of subjects: 260
Study 35301596 — intervention group
Group type: COMPARATOR
Intervention: Control group for office bleaching
Number of subjects: 260
Study 35301596 — intervention group
Group type: COMPARATOR
Intervention: Control group for home bleaching
Number of subjects: 260
Study 33565010 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic low-pressure cholecystectomy (LPLC) at 8 mmHg
Number of subjects: 100
Study 33565010 — intervention group
Group type: COMPARATOR
Intervention: Standard pressure laparoscopic cholecystectomy (SPLC) at 12 mmHg
Number of subjects: 100
Study 35929765 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mm laterally wedged insole
Number of subjects: 28
Study 35929765 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis
Number of subjects: 28
Study 32286683 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodalumab
Number of subjects: 442
Study 32286683 — intervention group
Group type: COMPARATOR
Intervention: Brodalumab after placebo
Number of subjects: 442
Study 33301738 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral panobinostat 20 mg three times weekly
Number of subjects: 248
Study 33301738 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral panobinostat 20 mg twice weekly
Number of subjects: 248
Study 33301738 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral panobinostat 10 mg three times weekly
Number of subjects: 248
Study 33031887 — intervention group
Group type: EXPERIMENTAL
Intervention: M->A (adhesive applied before matrix application)
Number of subjects: 20
Study 33031887 — intervention group
Group type: EXPERIMENTAL
Intervention: A->M (adhesive applied after matrix application)
Number of subjects: 20
Study 33031887 — intervention group
Group type: EXPERIMENTAL
Intervention: CU + CV (Clearfil Universal Bond Quick with crystal violet dye)
Number of subjects: 20
Study 33031887 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE (Clearfil SE Bond2)
Number of subjects: 20
Study 33031887 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE with CV addition
Number of subjects: 20
Study 33507601 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment avoidance as a mediator
Number of subjects: 206
Study 33507601 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived relatedness
Number of subjects: 206
Study 36207474 — intervention group
Group type: EXPERIMENTAL
Intervention: AI/ML-based CAD devices for detection of colorectal polyps
Number of subjects: 45
Study 36207474 — intervention group
Group type: COMPARATOR
Intervention: Standalone software testing for AI/ML-based CAD devices
Number of subjects: 45
Study 34016665 — intervention group
Group type: EXPERIMENTAL
Intervention: UK official information (no mention of false negatives/positives)
Number of subjects: 1744
Study 34016665 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional information)
Number of subjects: 1744
Study 34016665 — intervention group
Group type: EXPERIMENTAL
Intervention: New Zealand wording (highlighted uncertainties)
Number of subjects: 1744
Study 34016665 — intervention group
Group type: EXPERIMENTAL
Intervention: New Zealand wording
Number of subjects: 1744
Study 34016665 — intervention group
Group type: EXPERIMENTAL
Intervention: UK wording
Number of subjects: 1744
Study 34016665 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive results
Number of subjects: 1744
Study 32097286 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace program of moderate intensity exercises for 7 weeks
Number of subjects: 0
Study 32097286 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercises illustrated in a booklet and video for 7 weeks
Number of subjects: 0
Study 36268789 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg (maximum of 5 mg) of dexamethasone diluted to a total volume of 2 ml with 0.9% saline (n = 50)
Number of subjects: 100
Study 36268789 — intervention group
Group type: COMPARATOR
Intervention: 2 ml of 0.9% saline (n = 50)
Number of subjects: 100
Study 36268789 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg (maximum of 5 mg) of dexamethasone
Number of subjects: 100
Study 32951502 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish Renal Registry (SRR) data on vascular access
Number of subjects: 120
Study 32951502 — intervention group
Group type: EXPERIMENTAL
Intervention: SRR registrations
Number of subjects: 120
Study 32951502 — intervention group
Group type: EXPERIMENTAL
Intervention: Registrations of central venous catheters (CVCs)
Number of subjects: 120
Study 32951502 — intervention group
Group type: EXPERIMENTAL
Intervention: Registrations of placed fistulas in 2017
Number of subjects: 120
Study 32951502 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular access type initiating hemodialysis
Number of subjects: 120
Study 33151802 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate injections via superolateral, anteromedial or anterolateral portals
Number of subjects: 111
Study 35987467 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam plus metronidazole
Number of subjects: 0
Study 35987467 — intervention group
Group type: COMPARATOR
Intervention: Meropenem plus placebo
Number of subjects: 0
Study 33548338 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy
Number of subjects: 442
Study 33548338 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 442
Study 33548338 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline neutrophilia
Number of subjects: 442
Study 33548338 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated or increasing neutrophil count after induction chemotherapy
Number of subjects: 442
Study 33548338 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated or increasing neutrophil count
Number of subjects: 442
Study 35616304 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 24
Study 35616304 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory exercise
Number of subjects: 24
Study 34688915 — intervention group
Group type: EXPERIMENTAL
Intervention: Identify, Coordinate, and Enhance (ICE) care model
Number of subjects: 2971
Study 34688915 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Postural Therapy (IPT)
Number of subjects: 2971
Study 34688915 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2971
Study 33558215 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary temperature measurement
Number of subjects: 72
Study 33558215 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal temperature measurement
Number of subjects: 72
Study 33558215 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal and axillary temperature measurements
Number of subjects: 72
Study 33186338 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate antiretroviral therapy
Number of subjects: 207
Study 33186338 — intervention group
Group type: COMPARATOR
Intervention: Deferred antiretroviral therapy
Number of subjects: 207
Study 35331432 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein of Marshall ethanol infusion (VOMEt) as first step preceding RF ablation (VOMFIRST group)
Number of subjects: 70
Study 35331432 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency (RF) ablation as a first step preceding VOMEt (RFFIRST group)
Number of subjects: 70
Study 35331432 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups after additional touch-up RF ablation
Number of subjects: 70
Study 34781656 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous Pegylated erythropoietin at a dose of 0.6 mcg/kg body weight, once every two weeks along with intravenous iron 100 mg/week for 3 months.
Number of subjects: 40
Study 34781656 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous darbepoetin alfa at a dose of 0.45 mcg/kg body weight once weekly along with intravenous iron 100 mg/week for 3 months.
Number of subjects: 40
Study 34114138 — intervention group
Group type: EXPERIMENTAL
Intervention: Brinzolamide-brimonidine fixed combination (1 drop, instilled 2 hours before injection)
Number of subjects: 47
Study 34114138 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylactic medication)
Number of subjects: 47
Study 32853281 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular stimulation (AS)
Number of subjects: 37
Study 32853281 — intervention group
Group type: COMPARATOR
Intervention: Expressive writing (EW)
Number of subjects: 37
Study 32853281 — intervention group
Group type: COMPARATOR
Intervention: No intervention (NI)
Number of subjects: 37
Study 32567474 — intervention group
Group type: EXPERIMENTAL
Intervention: SB fermented with Lactobacillus casei TH14, cellulase, and molasses
Number of subjects: 0
Study 32567474 — intervention group
Group type: COMPARATOR
Intervention: Rice straw (RS)
Number of subjects: 0
Study 32567474 — intervention group
Group type: COMPARATOR
Intervention: SB
Number of subjects: 0
Study 33690610 — intervention group
Group type: EXPERIMENTAL
Intervention: Pratt pouch model dispensing nevirapine prophylaxis
Number of subjects: 660
Study 33690610 — intervention group
Group type: COMPARATOR
Intervention: Standard nevirapine syrup
Number of subjects: 660
Study 35239204 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5674
Study 35239204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5674
Study 32501994 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (heat-clearing and detoxifying Chinese medicines combined with conventional therapy)
Number of subjects: 947
Study 32501994 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 947
Study 32501994 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinlianqingre effervescent tablets (part of combination therapy)
Number of subjects: 947
Study 32501994 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 947
Study 37079268 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment group (App + usual care)
Number of subjects: 197
Study 37079268 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 197
Study 36432446 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app and smart band (Mi Band 2, Xiaomi) for 3 months
Number of subjects: 253
Study 36432446 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 253
Study 32346959 — intervention group
Group type: EXPERIMENTAL
Intervention: TAZ/BM cream
Number of subjects: 600
Study 32346959 — intervention group
Group type: COMPARATOR
Intervention: TAZ gel
Number of subjects: 600
Study 32346959 — intervention group
Group type: COMPARATOR
Intervention: BM cream
Number of subjects: 600
Study 35092347 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine and chelation therapy
Number of subjects: 64
Study 35092347 — intervention group
Group type: COMPARATOR
Intervention: Chelation therapy only
Number of subjects: 64